Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  United Therapeutics Corporation    UTHR

Delayed Quote. Delayed  - 02/11 03:59:59 pm
121.61 USD   +1.56%
02/05UNITED THERAPEU : Perfect timing to aim a technical rebound
01/20 UNITED THERAPEU : Mayo Clinic's lung restoration center ready to bre..
01/06 UNITED THERAPEU : To Present At 34th Annual J.P. Morgan Healthcare C..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 740 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,117100%1,289100% +13.31%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States1,03292.4%1,18191.6% +12.56%
Rest-of-World84.557.6%107.768.4% +21.54%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA611996Chairman & Co-Chief Executive Officer
Roger A. Jeffs, PhD551998President, Co-Chief Executive Officer & Director
David Zaccardelli, PhD512004Chief Operating Officer & Executive Vice President
James Edgemond482013Chief Financial Officer & Treasurer
Raymond C. Kurzweil, PhD672002Independent Director
Louis Wade Sullivan, MD812013Independent Director
Raymond Allen Dwek732002Non-Independent Director
Christopher Patusky512002Vice Chairman
Christopher Causey, MBA522003Independent Director
Richard Giltner512009Independent Director
Shareholders
NameEquities%
Fidelity Management & Research Co. 3,969,774 8.70%
BlackRock Fund Advisors 3,702,515 8.11%
The Vanguard Group, Inc. 3,140,363 6.88%
Scopia Capital Management LP 2,845,869 6.24%
SSgA Funds Management, Inc. 1,606,575 3.52%
Palo Alto Investors LLC 1,524,254 3.34%
BlackRock Advisors LLC 1,433,332 3.14%
AQR Capital Management LLC 1,303,155 2.86%
AJO LP 1,228,370 2.69%
BlackRock Investment Management LLC 1,203,835 2.64%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
CELLTRION, INC.
LONZA GROUP AG
QUINTILES TRANSNA..
UNITED THERAPEUTI..
QIAGEN NV
ALNYLAM PHARMACEU..
ALKERMES PLC
IONIS PHARMACEUTI..
ICON PLC
SEATTLE GENETICS,..
INTREXON CORP
CHARLES RIVER LAB..
WUXI PHARMATECH (..
BIO-TECHNE CORP
PAREXEL INTERNATI..
ANACOR PHARMACEUT..
BB BIOTECH AG
-
PRA HEALTH SCIENC..
ACADIA PHARMACEUT..
Sector Biotechnology & Medical Research
United Therapeutics Corpor : Connections
Patusky Associates LLC
Project HOPE-The-People-To-People HealthFoundation, Inc.
Kurzweil Technologies, Inc.
Medical Learning Co., Inc.
University of Oxford
FatKat, Inc.
Synthetic Genomics, Inc.
X PRIZE Foundation
Google, Inc.
Morehouse School of Medicine
The Sullivan Alliance
Oxford Glycobiology Institute
Public Broadcasting Atlanta
Slater Run Vineyards LLC
Association of Public Television Stations
Causey Consortium
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
© 2016 People , Fundamentals and Ownership